Article citationsMore>>

M. E. Pavel, J. D. Hainsworth, E. Baudin, M. Peeters, D. Horsch, R. E. Winkler, et al., “Everolimus Plus Octreotide Long-Acting Repeatable for the Treatment of Advanced Neuroendocrine Tumours Associated with Carcinoid Syndrome (RADIANT 2): A Randomised, PlaceboControlled, Phase 3 Study,” The Lancet, Vol. 378, No. 9808, 2011, pp. 2005-2012. doi:10.1016/S0140-6736(11)61742-X

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.